Highlights and Quick Summary
Current Free Cash Flow Yield of BridgeBio Pharma, Inc. is -21.23% (as of December 31, 2021)
- Free Cash Flow Yield for the quarter ending September 30, 2022 was -34.22% (a -0.67% decrease compared to previous quarter)
- Year-over-year quarterly Free Cash Flow Yield increased by 61.19%
- Annual Free Cash Flow Yield for 2021 was -21.23% (a 337.73% increase from previous year)
- Annual Free Cash Flow Yield for 2020 was -4.85% (a -30.32% decrease from previous year)
Visit stockrow.com/BBIO
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical Free Cash Flow Yield of BridgeBio Pharma, Inc.
Most recent Free Cash Flow Yieldof BBIO including historical data for past 10 years.Interactive Chart of Free Cash Flow Yield of BridgeBio Pharma, Inc.
BridgeBio Pharma, Inc. Free Cash Flow Yield for the past 10 Years (both Annual and Quarterly)
| Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
|---|---|---|---|---|---|
| 2022 | – | -34.22% | -34.45% | -35.11% | – |
| 2021 | -21.23% | -6.89% | -5.34% | -5.52% | -21.23% |
| 2020 | – | – | -4.85% | -8.72% | -4.85% |
| 2019 | -6.96% | -8.97% | – | – | -6.96% |
Business Profile of BridgeBio Pharma, Inc.
Sector: Healthcare
Industry: Biotechnology